Making Medically Assisted Treatment (MAT) Safer and Effective Through the Fusion of EHR Data, Biometrics, and AI.
We are pioneering a historic milestone by introducing the capability to monitor Opioid Use Disorder (OUD) patients beyond the confines of the clinic for the first time ever.
Break Free from Clinic Limitations
Treating an Opioid Use Disorder (OUD) patient without access to biometric insights is akin to expecting an endocrinologist to manage diabetic patients without a glucometer—it would be unsafe and inefficient. Now, with the integration of biometric insights, clinicians finally have the equivalent of a "Glucometer" for OUD treatment, providing them with the objective data necessary to effectively manage their patients' recovery.
Don't Miss Critical Patient Insights
OpiAID provides timely and actionable insights and is in the process of developing metrics that will allow for measuring withdrawal quantification comparable to the way glucometers are being used to monitor diabetics today.
Unlock Personalized Treatment Plans
Every patient's response to MAT treatment varies based on their unique physiological reactions and the specific types and potency of substances they have used. Biometric insights now make it possible to personalize treatment according to each patient's individual response, allowing for a more tailored and effective approach to their recovery.
Through Partnerships - Comprehensive Support for Recovery
Recovery doesn’t solely occur within the clinical environment. The patient's support network extends into the community. OpiAID's community partnership tools help keep the patient's support network informed of their progress while assisting the patient in better understanding the expectations for their own personal journey.
Data Collation, Simplifying Care
Integrating diverse patient data can be challenging. OpiAID's seamless integration simplifies this process by consolidating information from various sources into a unified database for comprehensive patient care.
Informed Decisions, Better Outcomes
OpiAID delivers actionable alerts with advanced biometric insights, enabling clinicians to make informed decisions promptly while ensuring that every decision contributes to improved treatment outcomes.
Join OpiAID on the journey to comprehensive and effective patient care. Embrace real-time insights, personalized support, and optimized recovery outcomes.
Opiaid’s AI-enabled wearables redefine addiction treatment, offering real-time monitoring, biometric insights, quantified treatment plans, personalized support, seamless integration, and clinically valid alerts. Our comprehensive solution could enhance patient care, improve treatment outcomes, and contribute to the overall effective Substance Use Disorder (SUD).
Real-time Monitoring keeps clinicians connected beyond clinic walls, using wearable devices to track patient progress continuously.
Yes, the OpiAID app will empower family and peer support specialists to actively assist patients on their recovery journey.
OpiAID’s Real-time Monitoring is compatible with a range of wrist-worn devices to ensure flexibility and convenience for patients.
OpiAID utilizes advanced AI algorithms to analyze raw biometric data, providing clinicians with quantifiable insights into withdrawal symptoms. * Pending FDA Clearance
Yes, OpiAID’s wearables seamlessly integrate with existing EHR systems, ensuring efficient data management and accessibility for clinicians.
Yes, OpiAID provides customization options for Clinically Valid Alerts, allowing clinicians to tailor alerts based on individual patient needs and preferences.
OpiAID follows rigorous security protocols and complies with industry standards to ensure the security and confidentiality of patient data at all times. OpiAID does not collect PII linking biometrics to an individual participant.
Absolutely, OpiAID’s wearables are designed to support patients undergoing MAT, providing valuable insights and support throughout the treatment process.
Yes, OpiAID offers comprehensive support and training for clinicians to ensure they make the most out of the AI wearables, enhancing their patient care capabilities.
OpiAID’s innovative solutions are designed to improved retention in treatment leading to improved patient outcomes resulting in minimizing relapses, hospital visits, and emergency interventions.
Yes, Opiaid encourages patient engagement by providing secure access to their own biometric data through the platform, fostering a collaborative approach to treatment. * future pending.
Sign up to use OpiAID’s wearable technology today and take advantage of advanced insights into your recovery, improved outcomes, and an unmatched network of support to help guide you through your recovery.
Discover OpiAID, a leading data science company providing innovative solutions for treatment for substance dependence. Elevate patient care with actionable insights and AI-enabled wearable technology.